Cargando…
Oncolytic efficacy of thymidine kinase-deleted vaccinia virus strain Guang9
Oncolytic virotherapy is being developed as a promising platform for cancer therapy due to its ability to lyse cancer cells in a tumor-specific manner. Vaccinia virus has been used as a live vaccine in the smallpox eradication program and now is being potential in cancer therapy with a great safety...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522336/ https://www.ncbi.nlm.nih.gov/pubmed/28465492 http://dx.doi.org/10.18632/oncotarget.17125 |